Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › WA › Edmonds › NPI 1033107214
Hospital

Swedish Edmonds

Swedish Edmonds was paid $30.06M by Medicaid between Jan 2018 and Dec 2024, across 362 billing codes. Its largest line is 96361, Intravenous infusion, hydration; each additional hour — 15% of everything it billed.

33Billing provider infoSWEDISH EDMONDS
EDMONDS, WA 98026
33aNPI1033107214assigned 10/11/2005
33bProvider typePsychiatric Hospital Unit
28Total paid$30.06M
24GClaims1,095,402
24DCodes billed362
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Psychiatric Hospital Unit providers in Washington

Rank by total paid#4 of 11
Median peer was paid$15K
This provider vs. median2,051×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018155,207$4.63M
2019157,421$4.58M
2020137,621$3.71M
2021167,166$4.42M
2022159,616$4.23M
2023172,362$4.52M
2024incomplete146,009$3.99M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
96361 Intravenous infusion, hydration; each additional hour 15% 15,185 12,974 $4.41M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 12% 33,267 31,185 $3.70M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 9.1% 31,103 28,723 $2.73M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 7.8% 28,628 26,230 $2.36M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 5.6% 24,962 18,960 $1.68M
74177 Computed tomography, abdomen and pelvis; with contrast material 4.2% 7,429 7,154 $1.25M
70450 Computed tomography, head or brain; without contrast material 2.7% 6,830 6,470 $813K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 2.7% 4,001 3,944 $813K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.3% 8,224 7,825 $705K
59025 Fetal non-stress test 2.1% 3,874 2,724 $633K
45380 Colonoscopy, flexible; with biopsy, single or multiple 1.9% 1,694 1,664 $572K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 1.7% 2,479 2,007 $520K
350 more codes
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.6% 5,361 $480K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 1.5% 809 $438K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.4% 4,291 $423K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1.4% 4,966 $414K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.3% 2,418 $379K
71275 Computed tomographic angiography, chest, with contrast material 1.2% 2,296 $365K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.2% 11,643 $361K
99281 Emergency department visit for the evaluation and management, self-limited or minor 1.2% 2,944 $358K
76705 Ultrasound, abdominal, real time with image documentation; limited 1.2% 4,076 $350K
95810 Polysomnography; sleep staging with 4 or more additional parameters 1.1% 670 $317K
76642 <1% 3,412 $288K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 10,788 $245K
29581 <1% 1,631 $233K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 790 $227K
76830 Ultrasound, transvaginal <1% 2,561 $205K
80053 Comprehensive metabolic panel <1% 47,450 $191K
77067 Screening mammography, bilateral, including computer-aided detection <1% 4,683 $173K
93017 <1% 2,206 $172K
47562 <1% 70 $166K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 533 $155K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 619 $131K
12001 <1% 614 $123K
93350 <1% 646 $123K
70498 <1% 1,316 $118K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 2,809 $117K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 4,599 $105K
95811 <1% 240 $104K
97535 Self-care/home management training, each 15 minutes <1% 5,329 $102K
70496 <1% 1,355 $98K
93970 <1% 981 $94K
76801 <1% 1,991 $93K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 5,003 $90K
70551 Magnetic resonance imaging, brain; without contrast material <1% 625 $90K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 3,697 $85K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 4,019 $83K
10060 <1% 367 $77K
84484 <1% 19,233 $76K
97162 <1% 1,882 $74K
80048 Basic metabolic panel (calcium, ionized) <1% 16,180 $73K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 499 $70K
78815 Positron emission tomography (PET) for limited area imaging <1% 117 $69K
77066 Tomosynthesis, mammo <1% 2,303 $65K
77065 Tomosynthesis, mammo <1% 2,083 $64K
77063 Screening digital breast tomosynthesis, bilateral <1% 4,006 $58K
G0378 Hospital observation service, per hour <1% 10,865 $56K
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk <1% 79 $53K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 5,208 $50K
71046 Radiologic examination, chest; 2 views <1% 9,053 $49K
83605 <1% 10,482 $47K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 1,004 $47K
93321 <1% 654 $46K
84443 Thyroid stimulating hormone (TSH) <1% 8,800 $38K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,828 $37K
97161 <1% 1,063 $37K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 1,428 $35K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 61,207 $35K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 246 $35K
93971 <1% 406 $33K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 1,677 $33K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 2,265 $32K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 26,686 $30K
87631 <1% 585 $29K
76536 <1% 329 $27K
72125 Computed tomography, cervical spine; without contrast material <1% 2,249 $26K
87040 <1% 4,542 $26K
12011 <1% 133 $25K
80061 Lipid panel <1% 5,749 $24K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 1,797 $24K
83880 <1% 4,626 $24K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 24,955 $24K
93325 <1% 865 $23K
70491 <1% 131 $23K
36415 Collection of venous blood by venipuncture <1% 32,000 $22K
84145 <1% 2,803 $20K
90715 <1% 1,176 $20K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 3,549 $19K
85379 <1% 3,603 $18K
76770 <1% 211 $18K
72100 <1% 1,546 $17K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,787 $16K
83036 Hemoglobin; glycosylated (A1C) <1% 8,022 $16K
82728 <1% 2,745 $15K
80047 <1% 3,228 $15K
87086 Culture, bacterial; quantitative colony count, urine <1% 7,985 $15K
93978 <1% 358 $15K
87507 <1% 202 $14K
73030 <1% 1,871 $13K
80050 General health panel <1% 2,471 $13K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 368 $12K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 920 $12K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,823 $12K
86780 <1% 2,253 $12K
86803 <1% 1,764 $12K
87634 <1% 681 $11K
84702 <1% 6,344 $11K
74018 <1% 1,432 $11K
71045 Radiologic examination, chest; single view <1% 12,253 $10K
19083 <1% 12 $10K
73630 <1% 1,943 $10K
82607 <1% 1,687 $10K
76819 Fetal biophysical profile; without non-stress testing <1% 164 $10K
85027 <1% 5,217 $9K
97597 <1% 98 $9K
73564 <1% 2,060 $8K
49083 <1% 43 $8K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 1,875 $8K
95819 <1% 51 $8K
86140 <1% 5,412 $8K
82553 <1% 1,328 $8K
84439 <1% 2,106 $8K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 12 $8K
73130 <1% 1,482 $8K
81001 <1% 26,101 $8K
73610 <1% 1,982 $8K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 2,101 $7K
64483 <1% 13 $7K
84466 <1% 1,830 $7K
29125 <1% 28 $7K
P9016 Red blood cells, leukocytes reduced, each unit <1% 15 $7K
87158 <1% 797 $7K
70486 <1% 205 $7K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 10,009 $7K
62323 <1% 27 $6K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 62 $5K
84153 <1% 712 $5K
71250 <1% 137 $5K
73502 <1% 775 $5K
82962 <1% 22,980 $5K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 71 $5K
36430 <1% 122 $5K
83540 <1% 1,839 $5K
86762 <1% 1,056 $5K
84403 <1% 657 $4K
73110 <1% 1,097 $4K
97116 <1% 380 $4K
96375 Therapeutic injection; each additional sequential IV push <1% 18,209 $4K
97802 <1% 66 $4K
83735 <1% 6,170 $4K
83970 <1% 243 $4K
80076 <1% 1,268 $4K
76870 <1% 45 $4K
87340 <1% 1,402 $4K
86850 <1% 3,068 $3K
86480 <1% 271 $3K
83690 <1% 15,654 $3K
97803 <1% 87 $3K
12002 <1% 24 $3K
84146 <1% 485 $3K
J1650 Injection, enoxaparin sodium, 10 mg <1% 2,744 $3K
97035 <1% 433 $3K
73562 <1% 95 $3K
85652 <1% 3,467 $3K
87503 <1% 605 $3K
86901 <1% 3,975 $3K
82746 <1% 560 $3K
86900 <1% 3,896 $2K
87186 <1% 2,334 $2K
83001 <1% 493 $2K
87205 <1% 2,281 $2K
85610 <1% 5,758 $2K
82950 <1% 649 $2K
82570 <1% 1,181 $2K
87070 <1% 2,068 $2K
87077 <1% 1,665 $2K
87660 <1% 423 $2K
82670 <1% 288 $2K
80143 <1% 188 $2K
84481 <1% 667 $2K
73140 <1% 224 $2K
97165 <1% 53 $2K
87081 <1% 1,176 $2K
82043 <1% 829 $2K
86787 <1% 312 $1K
82075 <1% 1,382 $1K
82565 <1% 1,266 $1K
87641 <1% 233 $1K
72131 <1% 52 $1K
71101 <1% 249 $1K
96376 <1% 7,023 $1K
94726 <1% 27 $1K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,353 $1K
87480 <1% 423 $1K
82077 <1% 1,978 $1K
97163 <1% 26 $1K
87510 <1% 423 $1K
84100 <1% 1,776 $1K
82550 <1% 2,878 $1K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 15 $1K
84550 <1% 644 $995.15
73080 <1% 232 $991.92
86706 <1% 252 $991.05
73590 <1% 292 $959.41
84703 <1% 6,126 $941.83
81025 <1% 5,635 $941.43
J3010 Injection, fentanyl citrate, 0.1 mg <1% 8,434 $906.56
94729 <1% 40 $903.03
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 2,976 $895.00
72040 <1% 52 $889.19
83002 <1% 187 $832.22
85014 <1% 552 $729.53
86364 <1% 112 $680.37
86677 <1% 145 $671.89
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 887 $666.84
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 16,430 $660.33
84156 <1% 356 $613.11
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 13,787 $605.09
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 14,013 $600.25
87430 <1% 951 $576.72
87210 <1% 1,436 $573.91
80179 <1% 604 $567.30
J1170 Injection, hydromorphone, up to 4 mg <1% 7,987 $546.20
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 3,187 $521.91
82803 <1% 3,115 $437.13
86923 <1% 31 $436.07
82105 <1% 62 $416.35
87147 <1% 348 $401.46
87653 <1% 21 $364.57
J2270 Injection, morphine sulfate, up to 10 mg <1% 6,626 $363.92
81003 <1% 1,311 $361.08
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 1,612 $360.37
93798 <1% 62 $321.26
86038 <1% 90 $320.15
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 7,203 $318.38
90686 <1% 32 $305.71
82784 <1% 111 $304.04
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 41 $303.07
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 6,409 $301.67
84402 <1% 67 $286.35
87075 <1% 610 $268.82
74019 <1% 16 $260.88
J7030 Infusion, normal saline solution , 1000 cc <1% 6,917 $246.00
87188 <1% 1,149 $244.78
86376 <1% 59 $240.12
C1769 Guide wire <1% 951 $230.74
99153 Mod sedat endo service >5yrs <1% 806 $220.55
85730 <1% 1,858 $206.68
73090 <1% 52 $205.39
82951 <1% 26 $204.00
87338 <1% 39 $202.32
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 5,690 $201.23
J2704 Injection, propofol, 10 mg <1% 6,821 $188.40
87220 <1% 515 $171.15
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 6,390 $160.51
88342 <1% 413 $152.32
A9585 Injection, gadobutrol, 0.1 ml <1% 1,745 $149.88
80178 <1% 27 $148.58
80069 <1% 28 $144.60
85018 <1% 163 $134.59
J3490 Unclassified drugs <1% 916 $131.98
88304 <1% 1,010 $129.31
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 808 $125.03
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 895 $123.65
99152 <1% 715 $120.37
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 3,511 $113.97
80164 <1% 29 $109.05
87486 <1% 12 $106.92
36591 <1% 38 $99.76
G0379 Direct admission of patient for hospital observation care <1% 26 $98.36
G0008 Administration of influenza virus vaccine <1% 13 $95.04
84445 <1% 16 $94.12
86735 <1% 27 $88.73
A9270 Non-covered item or service <1% 17,338 $88.06
0353U <1% 1,274 $87.83
J2060 Injection, lorazepam, 2 mg <1% 3,476 $86.86
J0780 Injection, prochlorperazine, up to 10 mg <1% 1,675 $83.95
J2785 Injection, regadenoson, 0.1 mg <1% 340 $83.45
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 1,632 $82.36
J3370 Injection, vancomycin hcl, 500 mg <1% 1,059 $78.63
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 338 $75.08
86765 <1% 25 $73.74
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 805 $73.53
J1815 Injection, insulin, per 5 units <1% 3,502 $69.92
82533 <1% 14 $68.51
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 12 $66.15
87581 <1% 12 $66.15
82247 <1% 16 $65.73
0352U <1% 539 $64.48
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 844 $61.24
84144 <1% 13 $60.67
82010 <1% 459 $57.34
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 3,237 $55.63
74022 <1% 59 $54.67
J7050 Infusion, normal saline solution, 250 cc <1% 5,991 $54.35
J7120 Ringers lactate infusion, up to 1000 cc <1% 4,998 $54.33
83615 <1% 24 $42.89
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) <1% 735 $40.07
86703 <1% 14 $39.96
86704 <1% 13 $35.50
82977 <1% 12 $31.75
82248 <1% 14 $28.33
82140 <1% 28 $25.82
86308 <1% 52 $18.76
95249 <1% 95 $16.27
J0690 Injection, cefazolin sodium, 500 mg <1% 2,691 $14.19
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 33 $13.27
87071 <1% 39 $11.56
J1630 Injection, haloperidol, up to 5 mg <1% 617 $11.06
J3475 Injection, magnesium sulfate, per 500 mg <1% 922 $10.66
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 829 $6.80
87046 <1% 12 $6.29
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 2,624 $5.72
84520 <1% 14 $3.53
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 1,466 $2.82
C9113 Injection, pantoprazole sodium, per vial <1% 380 $2.68
J1644 Injection, heparin sodium, per 1000 units <1% 4,181 $2.39
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose <1% 326 $1.81
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 160 $0.25
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 0% 987 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 676 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 427 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 16,866 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 138 $0.00
87150 0% 299 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 0% 103 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 737 $0.00
Q9957 Injection, perflutren lipid microspheres, per ml 0% 78 $0.00
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 0% 99 $0.00
G8985 Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 80 $0.00
J0692 Injection, cefepime hydrochloride, 500 mg 0% 88 $0.00
M0222 Intravenous injection, bebtelovimab, includes injection and post administration monitoring 0% 12 $0.00
G8984 Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals 0% 77 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 94 $0.00
J2550 Injection, promethazine hcl, up to 50 mg 0% 29 $0.00
93356 0% 12 $0.00
C1758 Catheter, ureteral 0% 13 $0.00
J1040 Injection, methylprednisolone acetate, 80 mg 0% 137 $0.00
Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml 0% 68 $0.00
J7999 Compounded drug, not otherwise classified 0% 482 $0.00
G8981 Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals 0% 145 $0.00
C1889 Implantable/insertable device, not otherwise classified 0% 244 $0.00
0240U 0% 117 $0.00
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 0% 227 $0.00
G8982 Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 185 $0.00
J3360 Injection, diazepam, up to 5 mg 0% 30 $0.00
J1597 Injection, glycopyrrolate (glyrx-pf), 0.1 mg 0% 38 $0.00
G8987 Self care functional limitation, current status, at therapy episode outset and at reporting intervals 0% 91 $0.00
J1836 Injection, metronidazole, 10 mg 0% 376 $0.00
J3411 Injection, thiamine hcl, 100 mg 0% 58 $0.00
J3480 Injection, potassium chloride, per 2 meq 0% 60 $0.00
G8988 Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 109 $0.00
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting 0% 43 $0.00
J1790 Injection, droperidol, up to 5 mg 0% 19 $0.00
36416 0% 214 $0.00
J1010 Injection, methylprednisolone acetate, 1 mg 0% 29 $0.00
P9612 Catheterization for collection of specimen, single patient, all places of service 0% 13 $0.00
88341 0% 18 $0.00
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 0% 32 $0.00
J1940 Injection, furosemide, up to 20 mg 0% 78 $0.00
J1030 Injection, methylprednisolone acetate, 40 mg 0% 12 $0.00
A4648 Tissue marker, implantable, any type, each 0% 34 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialANDERSON, DONALD (ASSISTANT SECREATRY FOR ENROLLMENT)
Same official

Other billing entities under ANDERSON, DONALD

Full network →
ProviderLocationPaid
Providence Health & Services WashingtonAnchorage, AK$161.45M
Kadlec Regional Medical CenterRichland, WA$151.60M
ST. Joseph Health Northern California, LLCEureka, CA$28.68M
Providence Health System Southern CaliforniaTorrance, CA$27.29M
Providence Health System - Southern CaliforniaSan Pedro, CA$24.26M
Providence Health & Services - WashingtonTukwila, WA$21.98M
Swedish Health ServicesSeattle, WA$21.06M
Providence Health & Services WashingtonKodiak, AK$11.39M
Swedish Health ServicesSeattle, WA$11.08M
ST. Joseph Health Northern California, LLCFortuna, CA$8.55M
Collabria CareNapa, CA$8.20M
Providence Health & Services OregonSeaside, OR$8.01M
Providence Health & Services- WashingtonSpokane, WA$8.01M
Hospice of Lubbock INCLubbock, TX$6.48M
Providence Saint John's Health CenterSanta Monica, CA$5.52M
Methodist Hospital LevellandLevelland, TX$4.55M
Collabria CareNapa, CA$4.05M
Methodist Hospital LevellandLevelland, TX$4.01M
Methodist Hospital Plainview TexasPlainview, TX$4.00M
Providence Medical InstituteTorrance, CA$3.57M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.